Glibenclamide alters serotonin and dopamine levels in the rat striatum and hippocampus, reducing cognitive impairment

Rationale Glibenclamide (GD) is a widely used medical drug; therefore, identifying the mechanisms underlying its pleiotropic effects in the central nervous system is urgent. Objectives The aim of this work was to determine the ability of GD to modulate serotonin (5-hydroxytryptamine, 5-HT) and dopam...

Full description

Saved in:
Bibliographic Details
Published in:Psychopharmacology 2022-09, Vol.239 (9), p.2787-2798
Main Authors: Zubov, Alexander S., Ivleva, Irina S., Pestereva, Nina S., Tiutiunnik, Tatiana V., Traktirov, Dmitrtii S., Karpenko, Marina N.
Format: Article
Language:English
Subjects:
Aging
Analysis
Biomedical and Life Sciences
Biomedicine
Central nervous system
Cognitive ability
Corpus striatum
Dopamine
Dosage and administration
Dose-response relationship (Biochemistry)
Experiments
Glibenclamide
High-performance liquid chromatography
Hippocampus
Hippocampus (Brain)
Memory
Neostriatum
Neurosciences
Original Investigation
Pharmacology/Toxicology
Properties
Psychiatry
Serotonin
Short term memory
Spatial memory
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rationale Glibenclamide (GD) is a widely used medical drug; therefore, identifying the mechanisms underlying its pleiotropic effects in the central nervous system is urgent. Objectives The aim of this work was to determine the ability of GD to modulate serotonin (5-hydroxytryptamine, 5-HT) and dopamine (DA) transmission and to assess the dose-dependent effect of GD on cognitive function in rats during natural ageing. Methods In Experiment 1, rats received 10, 25, or 50 μg/kg GD intraperitoneally for 10 days. In Experiment 2, rats received 50 μg/kg GD intraperitoneally for 30 days. Spatial and working memory was assessed in the MWM and Y-maze tests, respectively. In both experiments, the levels of DA and 5-HT, their metabolites, and turnover rate were analysed by HPLC-ED in the rat hippocampus and striatum. Results Changes in DA and 5-HT levels occurred only with a dose of 50 μg/kg GD. Therefore, in the second experiment, we administered a dose of 50 μg/kg GD. At this dose, GD prevented the development of impairments in spatial and working memory. The hippocampal concentrations of DA and DOPAC decreased, and the striatal concentrations of DA, DOPAC, 5-HT, and 5-HIAA increased. Conclusion One of the possible mechanisms of the precognitive effect of GD is its ability to modulate monoamine transmission. Thus, in translating our results to humans, GD can be recommended as a prophylactic agent for natural ageing to reduce the risk of developing cognitive impairments.
ISSN:0033-3158
1432-2072
DOI:10.1007/s00213-022-06159-9